MTZ vs ZTS · P/E 63, rev $8.20B vs P/E 25, rev $2.47B
MasTec Inc (MTZ) versus Zoetis Inc (ZTS) — a side-by-side from cached financials, not a winner call.
MasTec Inc (MTZ) is a engineering & construction company listed on US.
Zoetis Inc (ZTS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported MTZ revenue for 2026-06-30 was $8.20B. Net income was $191.0M. MTZ currently screens at market cap $28.61B and trailing P/E 63.3.
Latest reported ZTS revenue for 2026-06-30 was $2.47B. Net income was $691.0M. Revenue was up 9.1% from 2026-03-31 to 2026-06-30. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
MTZ currently screens at market cap $28.61B and trailing P/E 63.3. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
Not investment advice. Open the MTZ and ZTS stock pages for the full models.
Not investment advice.